Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860470 · ClinicalTrials.gov registry record · Phase 3
Antenatal Micronutrient Supplementation and Infant Survival
A Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 44,567
- Enrollment target
NCT00860470: Completed Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT00860470 is a Phase 3 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 44,567 participants, above the 769-participant average among 15,282 other Phase 3 trials with a reported enrollment target (5695% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00860470, a Phase 3 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44,567 participants
- Enrollment target
Study Summary
The purpose of this community-based randomized trial is to examine whether a daily antenatal and postnatal multiple micronutrient supplement given to women will enhance newborn and infant survival and health and other birth outcomes in a rural setting in northwestern Bangladesh.
Primary Outcome
Infant Mortality to Age 6 months (180 days from birth)
Interventions
- DIETARY_SUPPLEMENT Iron (27 mg) - folic acid (600 ug)
- DIETARY_SUPPLEMENT Multiple micronutrient
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44,567 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
What the finished NCT00860470 record still lists
NCT00860470 is an interventional study that assigns participants to a tested intervention. Its 44,567 participants enrollment target places it among the larger protocols in the corpus, above the 769-participant average among 15,282 other Phase 3 trials with a reported enrollment target (5695% higher).
The record links to 0 conditions, and to 2 interventions - of which Iron (27 mg) - folic acid (600 ug) is the first listed.
NCT00860470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00860470 about?
NCT00860470 is a clinical study titled "Antenatal Micronutrient Supplementation and Infant Survival". The purpose of this community-based randomized trial is to examine whether a daily antenatal and postnatal multiple micronutrient supplement given to women will enhance newborn and infant survival and health and other birth outcomes in a rural setting in northwestern Bangladesh.
What is the current status of trial NCT00860470?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44,567 participants. The study started on 2008-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00860470?
The interventions under investigation include: Iron (27 mg) - folic acid (600 ug) (DIETARY_SUPPLEMENT), Multiple micronutrient (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00860470?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00860470's enrollment target sits among peer trials
44,567 3rd of 2000 higher than 1,998 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia